|
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.
|
18804908 |
2009 |
|
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
NF-kappa B genes have a major role in inflammatory breast cancer.
|
18248671 |
2008 |
|
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Acquisition of stable inducible up-regulation of nuclear factor-kappaB by tumor necrosis factor exposure confers increased radiation resistance without increased transformation in breast cancer cells.
|
18234964 |
2008 |
|
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression.
|
18316610 |
2008 |
|
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
|
18031796 |
2008 |
|
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity.
|
18505918 |
2008 |
|
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
|
18158619 |
2008 |
|
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
|
17620428 |
2007 |
|
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
Nuclear factor-kappaB accounts for the repressor effects of high stromal cell-derived factor-1alpha levels on Tac1 expression in nontumorigenic breast cells.
|
17409218 |
2007 |
|
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines.
|
17638883 |
2007 |
|
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Also, the amount of immunostained nuclei for RelB (P = 0.025) and NFkB1 (P = 0.031) was higher in ER- breast tumors versus ER+ breast tumors.
|
16740744 |
2006 |
|
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Also, the amount of immunostained nuclei for RelB (P = 0.025) and NFkB1 (P = 0.031) was higher in ER- breast tumors versus ER+ breast tumors.
|
16740744 |
2006 |
|
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB.
|
15688415 |
2005 |
|
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Intracellular inhibitory effects of Velcade correlate with morphoproteomic expression of phosphorylated-nuclear factor-kappaB and p53 in breast cancer cell lines.
|
15830705 |
2005 |
|
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
A cytoplasmic substrate of mitogen-activated protein kinase is responsible for estrogen receptor-alpha down-regulation in breast cancer cells: the role of nuclear factor-kappaB.
|
15056731 |
2004 |
|
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.
|
15044484 |
2004 |
|
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway.
|
12471041 |
2003 |
|
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer.
|
12867284 |
2003 |
|
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Additionally, the I kappa B homolog Bcl-3, which functions to stimulate transcription with p50 or p52, was also activated in breast tumors.
|
10713699 |
2000 |